Yousif Capital Management LLC Has $2.48 Million Stock Position in Laboratory Co. of America Holdings (NYSE:LH)

Yousif Capital Management LLC lessened its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 24.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 10,809 shares of the medical research company's stock after selling 3,519 shares during the period. Yousif Capital Management LLC's holdings in Laboratory Co. of America were worth $2,479,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. AMF Tjanstepension AB increased its holdings in shares of Laboratory Co. of America by 37.0% during the 3rd quarter. AMF Tjanstepension AB now owns 86,026 shares of the medical research company's stock worth $19,232,000 after purchasing an additional 23,221 shares during the period. CWM LLC increased its stake in Laboratory Co. of America by 41.0% during the third quarter. CWM LLC now owns 7,107 shares of the medical research company's stock valued at $1,588,000 after acquiring an additional 2,068 shares during the period. UMB Bank n.a. acquired a new position in Laboratory Co. of America in the 3rd quarter valued at approximately $84,000. Exchange Traded Concepts LLC lifted its position in shares of Laboratory Co. of America by 1,962.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 990 shares of the medical research company's stock worth $221,000 after acquiring an additional 942 shares during the period. Finally, Birch Hill Investment Advisors LLC grew its holdings in shares of Laboratory Co. of America by 0.9% during the 3rd quarter. Birch Hill Investment Advisors LLC now owns 140,358 shares of the medical research company's stock worth $31,367,000 after purchasing an additional 1,269 shares in the last quarter. Institutional investors own 95.94% of the company's stock.

Insiders Place Their Bets

In related news, CEO Adam H. Schechter sold 6,121 shares of Laboratory Co. of America stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $244.62, for a total transaction of $1,497,319.02. Following the transaction, the chief executive officer now owns 86,445 shares of the company's stock, valued at $21,146,175.90. This trade represents a 6.61 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Dwight Gary Gilliland sold 1,000 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $241.00, for a total transaction of $241,000.00. Following the completion of the sale, the director now directly owns 7,712 shares of the company's stock, valued at $1,858,592. The trade was a 11.48 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 24,504 shares of company stock valued at $5,905,692. Company insiders own 0.85% of the company's stock.

Laboratory Co. of America Price Performance

Shares of Laboratory Co. of America stock traded up $4.16 during midday trading on Thursday, reaching $245.31. The company had a trading volume of 485,466 shares, compared to its average volume of 609,361. The stock has a fifty day simple moving average of $236.92 and a 200 day simple moving average of $230.55. Laboratory Co. of America Holdings has a 1-year low of $191.97 and a 1-year high of $258.59. The company has a current ratio of 1.44, a quick ratio of 1.30 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $20.52 billion, a price-to-earnings ratio of 27.81, a price-to-earnings-growth ratio of 1.84 and a beta of 1.07.

Laboratory Co. of America (NYSE:LH - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The medical research company reported $3.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.40 by $0.05. Laboratory Co. of America had a return on equity of 15.29% and a net margin of 5.73%. As a group, equities research analysts forecast that Laboratory Co. of America Holdings will post 15.96 earnings per share for the current year.

Laboratory Co. of America Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 12th. Shareholders of record on Thursday, February 27th will be paid a $0.72 dividend. The ex-dividend date is Thursday, February 27th. This represents a $2.88 dividend on an annualized basis and a yield of 1.17%. Laboratory Co. of America's payout ratio is presently 32.65%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on LH. Evercore ISI raised shares of Laboratory Co. of America from an "in-line" rating to an "outperform" rating and boosted their price target for the company from $260.00 to $265.00 in a report on Tuesday, January 7th. UBS Group cut their price target on shares of Laboratory Co. of America from $293.00 to $286.00 and set a "buy" rating for the company in a research note on Tuesday, January 28th. Robert W. Baird upped their price objective on Laboratory Co. of America from $282.00 to $289.00 and gave the company an "outperform" rating in a research note on Friday, October 25th. Hsbc Global Res raised Laboratory Co. of America from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, October 30th. Finally, Piper Sandler increased their price objective on Laboratory Co. of America from $240.00 to $260.00 and gave the stock a "neutral" rating in a research note on Monday. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $265.31.

Laboratory Co. of America Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.